Specify a stock or a cryptocurrency in the search bar to get a summary
Thyrocare Technologies Limited
THYROCAREThyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
Analytics
WallStreet Target Price
66 195.67 INRP/E ratio
59.8829Dividend Yield
1.86 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures THYROCARE
Dividend Analytics THYROCARE
Dividend growth over 5 years
80 %Continuous growth
1 yearPayout Ratio 5 years average
96 %Dividend History THYROCARE
Stock Valuation THYROCARE
Financials THYROCARE
Results | 2019 | Dynamics |